Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Return on Equity (2021 - 2025)

Historic Return on Equity for Biofrontera (BFRIW) over the last 5 years, with Q3 2025 value amounting to 4.85%.

  • Biofrontera's Return on Equity rose 64100.0% to 4.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.85%, marking a year-over-year increase of 64100.0%. This contributed to the annual value of 3.85% for FY2024, which is 24500.0% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Return on Equity is 4.85%, which was up 64100.0% from 7.96% recorded in Q2 2025.
  • Biofrontera's 5-year Return on Equity high stood at 74.13% for Q1 2024, and its period low was 6.9% during Q4 2023.
  • Over the past 5 years, Biofrontera's median Return on Equity value was 1.08% (recorded in 2023), while the average stood at 5.21%.
  • In the last 5 years, Biofrontera's Return on Equity soared by 748000bps in 2024 and then tumbled by -788000bps in 2025.
  • Quarter analysis of 5 years shows Biofrontera's Return on Equity stood at 12.48% in 2021, then crashed by -100bps to 0.03% in 2022, then tumbled by -24969bps to 6.9% in 2023, then surged by 48bps to 3.56% in 2024, then surged by 236bps to 4.85% in 2025.
  • Its Return on Equity stands at 4.85% for Q3 2025, versus 7.96% for Q2 2025 and 4.67% for Q1 2025.